Quality Investor

Veralto Corporation

Rank #115Capital ReturnWatchlistCompare with other stocks

VLTO · NYSE · Industrials

Veralto Corporation (VLTO) — Rank #115 by gross profitability (GP/assets 0.43) · ROE 31.3% · Piotroski F-Score 5 / 9.

As-of 2026-10-30 · CIK 0001967680 · all metrics point-in-time as of the filing date.

About

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color solutions worldwide.

Show more

It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications under the Hach, Trojan Technologies, ChemTreat, and other brands. This segment also provides water solutions, including chemical reagents, services, and software solutions. The PQI segment offers marking and coding for packaged goods and related consumables; a software solution that provides digital asset management, marketing resource management, and product information management; inline printing solutions for products and packaging with marking and coding systems; design software and imaging systems for the creation of new packaging designs; color management solutions for printed packages and consumer and industrial products; and color standard services for the design industry. This segment sells its products and services through the Videojet, Linx, Esko, X-Rite, and Pantone brands. The company serves industries, such as municipal utilities, food and beverage, pharmaceutical, and industrials. The company was formerly known as DH EAS Holding Corp. and changed its name to Veralto Corporation in February 2023.

Veralto Corporation was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Industry
Pollution & Treatment Controls
Sector
Industrials
State
X1
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

17,000

Industry

Pollution & Treatment Controls

Exchange

NYSE

11/12

Flags passed

VLTO fails 1 critical flag

Passes 11 of 12 quality flags

  • FAIL
    Operating margin declining

    Operating margin lower than prior year

  • PASS
    Gross margin holding
  • PASS
    Dilution within 2%
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    Balance sheet stable
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Deferred revenue growing · RPO outpacing revenue · Sequential beat (rev + EPS)

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.43
Return on equity
31.3%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.55
Current ratio
1.48×
Net cash
-$1.23B

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.3%

Growth

2/2 pass
Revenue growth
6.0%
Piotroski F-Score
5 / 9
Share dilution
0.3%

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Does it make money well?

Warning: Operating margin declining · GP/assets 0.43

Gross profitability (GP / assets)

0.43

Primary signal (Novy-Marx).

1st of 5 SIC 3825 peers

Return on equity

31.3%

Gross margin

59.9%

1st of 5 SIC 3825 peers

Revenue growth (YoY)

6.0%

RPO growth (YoY)

10.9%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

4.2%

Revenue CAGR (5Y)

—

Earnings CAGR (3Y)

3.6%

FCF CAGR (3Y)

—

Cash Flow Health

Is the cash real?

No warning flags · FCF 8% above net income

Free cash flow

$1.01B

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

7.9%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.3%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

No warning flags · net debt $1.23B, F-Score 5/9

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.55

5th of 5 SIC 3825 peers (best = lowest)

Current ratio

1.48×

5th of 5 SIC 3825 peers

Quick ratio

1.19×

Net cash

-$1.23B

Cash & equivalents minus total debt.

Piotroski F-Score

5 / 9

Fundamental-strength score (0-9).

Valuation

Is the price reasonable?

No warning flags

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

24.7xCheap
24.7xmed 25.5x30.1x

P / S

Price / revenue per share

4.2xCheap
4.2xmed 4.4x4.8x

P / B

Price / book value per share

7.5xFair
6.7xmed 9.9x15.6x

P / GP

Price / gross profit per share

7.1xCheap
7.1xmed 7.8x8.1x

P / FCF

Price / free cash flow per share

23.0xCheap
23.0xmed 25.6x30.6x

Dividend safety

Composite score

3.0 / 5

Good
Payout ratio
11.6%5/5 Strong
FCF coverage
9.30×5/5 Strong
Dividend growth streak
1 yr1/5 Weak
Balance-sheet health
D/E 1.55 · IC N/A1/5 Weak

Capital allocation quality

Composite score

2.7 / 5

Fair
Share count trend
0.3%2/5 Fair
Buyback timing
N/AN/A
Dividend growth consistency
1 yr1/5 Weak
Net debt trajectory(deleveraging)
11.1%5/5 Strong

Lifecycle Phase History

20212025
Value
Capital Return